Company research

Explore company profiles, quarterly results, announcements and ownership disclosures.

Loading the company view…

3B Blackbio Dx Limited (3BBLACKBIO) — Stock Analysis

3B Blackbio Dx Limited (NSE: 3BBLACKBIO), ISIN INE994E01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.

3BBLACKBIO last traded at ₹1301.10 (+1.32%), with a 52-week range of ₹1085.00 to ₹1740.00 (as of 6 Nov 2026).

Shareholding as of Sep 2026: promoters 40.95%, FIIs 2.46%, DIIs 2.33%, mutual funds 0.00%.

EquiSense Score (ECS): 39/100.

Data sourced from NSE and BSE filings. Educational — not investment advice.